InsideArbitrage Potential Deal Alert: Germany’s Merck KGaA In Talks to Buy US Cancer Biotech Firm Springworks (SWTX)
Reuters reported that Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics
Read More